Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
PetMed Express initiated with an Underweight at Morgan Stanley » 08:37
11/18/21
11/18
08:37
11/18/21
08:37
PETS

PetMed Express

$30.12 /

-0.28 (-0.92%)

Morgan Stanley analyst…

Morgan Stanley analyst Erin Wright initiated coverage of PetMed Express with an Underweight rating and $25 price target. The company is highly levered to favorable underlying pet health demand and growing adoption of alternative mail-order pharmacy concepts, but will continue to face challenges in an increasingly competitive landscape, Wright tells investors.

ShowHide Related Items >><<
PETS PetMed Express
$30.12 /

-0.28 (-0.92%)

PETS PetMed Express
$30.12 /

-0.28 (-0.92%)

09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
PETS PetMed Express
$30.12 /

-0.28 (-0.92%)

PETS PetMed Express
$30.12 /

-0.28 (-0.92%)

PETS PetMed Express
$30.12 /

-0.28 (-0.92%)

Over a month ago
On The Fly
Fly Intel: After-Hours Movers » 18:40
10/25/21
10/25
18:40
10/25/21
18:40
UNFI

United Natural Foods

$43.98 /

-0.17 (-0.39%)

, HSII

Heidrick & Struggles

$46.03 /

+1.24 (+2.77%)

, TNET

TriNet

$97.20 /

+0.22 (+0.23%)

, CR

Crane

$93.36 /

-0.94 (-1.00%)

, MEDP

Medpace

$188.14 /

+1.52 (+0.81%)

, PKG

Packaging Corp.

$134.12 /

+ (+0.00%)

, IPAR

Inter Parfums

$77.80 /

+1.46 (+1.91%)

, FB

Facebook; also tag MVRS

$329.03 /

+4.35 (+1.34%)

, AMKR

Amkor Technology

$22.94 /

+0.655 (+2.94%)

, TBI

TrueBlue

$32.88 /

+0.735 (+2.29%)

, PETS

PetMed Express

$27.99 /

+0.945 (+3.49%)

, UHS

Universal Health

$133.69 /

-2.0098 (-1.48%)

, RNR

RenaissanceRe

$149.78 /

+2.19 (+1.48%)

, CDNS

Cadence Design

$167.35 /

+0.44 (+0.26%)

, CLAR

Clarus

$30.99 /

+0.54 (+1.77%)

Check out this evening's…

ShowHide Related Items >><<
UNFI United Natural Foods
$43.98 /

-0.17 (-0.39%)

UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

TNET TriNet
$97.20 /

+0.22 (+0.23%)

TBI TrueBlue
$32.88 /

+0.735 (+2.29%)

RNR RenaissanceRe
$149.78 /

+2.19 (+1.48%)

PKG Packaging Corp.
$134.12 /

+ (+0.00%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

MEDP Medpace
$188.14 /

+1.52 (+0.81%)

IPAR Inter Parfums
$77.80 /

+1.46 (+1.91%)

HSII Heidrick & Struggles
$46.03 /

+1.24 (+2.77%)

FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

CR Crane
$93.36 /

-0.94 (-1.00%)

CLAR Clarus
$30.99 /

+0.54 (+1.77%)

CDNS Cadence Design
$167.35 /

+0.44 (+0.26%)

UNFI United Natural Foods
$43.98 /

-0.17 (-0.39%)

10/05/21 Northcoast
United Natural Foods price target raised to $58 from $42 at Northcoast
10/05/21 Deutsche Bank
United Natural Foods price target raised to $48 from $35 at Deutsche Bank
09/30/21 BMO Capital
United Natural Foods price target raised to $50 from $36 at BMO Capital
09/29/21 MKM Partners
United Natural Foods price target raised to $59 from $46 at MKM Partners
HSII Heidrick & Struggles
$46.03 /

+1.24 (+2.77%)

04/27/21 Barrington
Heidrick & Struggles price target raised to $50 from $42 at Barrington
04/27/21 Truist
Heidrick & Struggles price target raised to $45 from $40 at Truist
02/24/21 Barrington
Barrington upgrades Heidrick & Struggles to Outperform, sees continued recovery
02/24/21 Barrington
Heidrick & Struggles upgraded to Outperform from Market Perform at Barrington
TNET TriNet
$97.20 /

+0.22 (+0.23%)

08/17/21 JPMorgan
TriNet price target raised to $100 from $89 at JPMorgan
07/13/21 William Blair
TriNet initiated with an Outperform at William Blair
02/17/21 Credit Suisse
TriNet price target raised to $80 from $66 at Credit Suisse
10/27/20 Credit Suisse
TriNet price target raised to $66 from $54 at Credit Suisse
CR Crane
$93.36 /

-0.94 (-1.00%)

09/08/21 BofA
Crane reinstated with a Buy at BofA
07/27/21 DA Davidson
Crane price target raised to $115 from $110 at DA Davidson
06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 DA Davidson
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment
MEDP Medpace
$188.14 /

+1.52 (+0.81%)

08/04/21 Credit Suisse
Medpace assumed with an Outperform at Credit Suisse
07/27/21 Truist
Medpace price target raised to $200 from $193 at Truist
07/20/21 Credit Suisse
Medpace price target raised to $205 from $200 at Credit Suisse
02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
PKG Packaging Corp.
$134.12 /

+ (+0.00%)

10/13/21 KeyBanc
Containerboard capacity in North America could rise with new mill, says KeyBanc
10/12/21 Truist
Truist starts Packaging Corp. at Hold, sees prices declining in 2022
10/12/21 Truist
Packaging Corp. initiated with a Hold at Truist
09/28/21 UBS
Packaging Corp. price target raised to $125 from $115 at UBS
IPAR Inter Parfums
$77.80 /

+1.46 (+1.91%)

08/11/21 BWS Financial
Inter Parfums price target raised to $100 from $80 at BWS Financial
08/11/21 Citi
Inter Parfums price target raised to $84 from $78 at Citi
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 DA Davidson
Inter Parfums upgraded to Buy from Neutral at DA Davidson
FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
AMKR Amkor Technology
$22.94 /

+0.655 (+2.94%)

10/11/21 Credit Suisse
Amkor Technology downgraded to Neutral from Outperform at Credit Suisse
02/11/21 Citi
Amkor Technology price target raised to $15 from $13 at Citi
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
Amkor Technology price target raised to $13 from $11.40 at Citi
TBI TrueBlue
$32.88 /

+0.735 (+2.29%)

06/09/21 Sidoti
Sidoti upgrades TrueBlue to Buy on better macro trends and positioning
06/09/21 Sidoti
TrueBlue upgraded to Buy from Neutral at Sidoti
04/27/21 Baird
Baird upgrades TrueBlue to Outperform on strengthening rebound
04/27/21 Baird
TrueBlue upgraded to Outperform from Neutral at Baird
PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

09/27/21 SVB Leerink
Universal Health initiated with a Market Perform at SVB Leerink
09/23/21 UBS
Universal Health initiated with a Sell at UBS
09/23/21 UBS
Universal Health initiated with a Sell at UBS
09/09/21 Cowen
Universal Health's behavioral unit suffers from execution stumbles, says Cowen
RNR RenaissanceRe
$149.78 /

+2.19 (+1.48%)

01/28/21 Wells Fargo
RenaissanceRe price target lowered to $220 from $229 at Wells Fargo
01/08/21 Goldman Sachs
RenaissanceRe upgraded to Conviction Buy from Neutral at Goldman Sachs
01/04/21 JPMorgan
RenaissanceRe price target raised to $162 from $160 at JPMorgan
CDNS Cadence Design
$167.35 /

+0.44 (+0.26%)

10/25/21 UBS
Cadence Design price target raised to $170 from $155 at UBS
10/21/21 Wells Fargo
Cadence Design price target raised to $175 from $165 at Wells Fargo
10/20/21
Fly Intel: Top five analyst initiations
10/20/21 Needham
Cadence Design initiated with a Buy at Needham
CLAR Clarus
$30.99 /

+0.54 (+1.77%)

10/21/21 Roth Capital
Clarus Q4 estimates need to move higher, says Roth Capital
10/19/21 DA Davidson
Clarus price target raised to $40 from $36 at DA Davidson
08/03/21 DA Davidson
Clarus price target raised to $36 from $31 at DA Davidson
08/03/21 Lake Street
Clarus price target raised to $35 from $33 at Lake Street
UNFI United Natural Foods
$43.98 /

-0.17 (-0.39%)

UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

TNET TriNet
$97.20 /

+0.22 (+0.23%)

TBI TrueBlue
$32.88 /

+0.735 (+2.29%)

RNR RenaissanceRe
$149.78 /

+2.19 (+1.48%)

PKG Packaging Corp.
$134.12 /

+ (+0.00%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

MEDP Medpace
$188.14 /

+1.52 (+0.81%)

IPAR Inter Parfums
$77.80 /

+1.46 (+1.91%)

HSII Heidrick & Struggles
$46.03 /

+1.24 (+2.77%)

FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

CR Crane
$93.36 /

-0.94 (-1.00%)

CLAR Clarus
$30.99 /

+0.54 (+1.77%)

CDNS Cadence Design
$167.35 /

+0.44 (+0.26%)

AMKR Amkor Technology
$22.94 /

+0.655 (+2.94%)

  • 27
    Oct
UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

CR Crane
$93.36 /

-0.94 (-1.00%)

AMKR Amkor Technology
$22.94 /

+0.655 (+2.94%)

UNFI United Natural Foods
$43.98 /

-0.17 (-0.39%)

UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

TNET TriNet
$97.20 /

+0.22 (+0.23%)

RNR RenaissanceRe
$149.78 /

+2.19 (+1.48%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

IPAR Inter Parfums
$77.80 /

+1.46 (+1.91%)

HSII Heidrick & Struggles
$46.03 /

+1.24 (+2.77%)

FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

CR Crane
$93.36 /

-0.94 (-1.00%)

CLAR Clarus
$30.99 /

+0.54 (+1.77%)

CDNS Cadence Design
$167.35 /

+0.44 (+0.26%)

AMKR Amkor Technology
$22.94 /

+0.655 (+2.94%)

UNFI United Natural Foods
$43.98 /

-0.17 (-0.39%)

UHS Universal Health
$133.69 /

-2.0098 (-1.48%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

FB Facebook; also tag MVRS
$329.03 /

+4.35 (+1.34%)

AMKR Amkor Technology
$22.94 /

+0.655 (+2.94%)

Earnings
PetMed Express reports Q2 EPS 31c, consensus 34c » 18:37
10/25/21
10/25
18:37
10/25/21
18:37
PETS

PetMed Express

$27.99 /

+0.945 (+3.49%)

Reports Q2 revenue…

Reports Q2 revenue $67.4M, consensus $72.45M. "PetMeds has been a pioneer in the business of pet health and wellness for over 25 years, and it's time to take the next step towards expanding our business in the $10 billion pet medication market and to begin our foray into the much larger $107 billion total pet care market," said Matt Hulett, CEO. "As one example, during the quarter we recently launched our "AutoShip and Save" program which allows us to build a greater lifetime value and recurring relationships with our customers. The team and I are looking forward to leveraging PetMeds' many assets in a variety of other new opportunity areas as we elevate our growth prospects for the future."

ShowHide Related Items >><<
PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

PETS PetMed Express
$27.99 /

+0.945 (+3.49%)

Options
PetMed Express options imply 12.2% move in share price post-earnings » 13:49
10/25/21
10/25
13:49
10/25/21
13:49
PETS

PetMed Express

$27.90 /

+0.86 (+3.18%)

Pre-earnings options…

Pre-earnings options volume in PetMed Express is 4.4x normal with calls leading puts 15:2. Implied volatility suggests the market is anticipating a move near 12.2%, or $3.41, after results are released. Median move over the past eight quarters is 5.3%.

ShowHide Related Items >><<
PETS PetMed Express
$27.90 /

+0.86 (+3.18%)

PETS PetMed Express
$27.90 /

+0.86 (+3.18%)

09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
PETS PetMed Express
$27.90 /

+0.86 (+3.18%)

PETS PetMed Express
$27.90 /

+0.86 (+3.18%)

Initiation
PetMed Express initiated with a Hold at Jefferies » 16:38
09/30/21
09/30
16:38
09/30/21
16:38
PETS

PetMed Express

$26.87 /

-1.11 (-3.97%)

Jefferies analyst…

Jefferies analyst Stephanie Wissink initiated coverage of PetMed Express with a Hold rating and $28 price target. The analyst sees the company returning to face "historical challenges" such as intensifying competition following a "temporary" COVID boost. Wissink adds that for PetMed Express multiple to see upside, its growth will need to accelerate. The analyst further states that investors await the new CEO's strategic vision.

ShowHide Related Items >><<
PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

09/30/21 Jefferies
PetMed Express initiated with a Hold at Jefferies
08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

Initiation
PetMed Express initiated with a Hold at Jefferies » 16:29
09/30/21
09/30
16:29
09/30/21
16:29
PETS

PetMed Express

$26.87 /

-1.11 (-3.97%)

Jefferies analyst…

Jefferies analyst Stephanie Wissink initiated coverage of PetMed Express with a Hold rating and $28 price target.

ShowHide Related Items >><<
PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
05/03/21 Credit Suisse
PetMed Express shares should decline on latest EPS miss, says Credit Suisse
PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

PETS PetMed Express
$26.87 /

-1.11 (-3.97%)

Over a quarter ago
Hot Stocks
PetMed Express appoints Matt Hulett as CEO, President, member of board » 08:13
08/31/21
08/31
08:13
08/31/21
08:13
PETS

PetMed Express

$28.70 /

+0.3 (+1.06%)

PetMed Express announced…

PetMed Express announced the appointment of Matt Hulett as its Chief Executive Officer and President, and member of the Board of Directors. Hulett has 30 years of experience with building consumer companies and was previously President of Rosetta Stone.

ShowHide Related Items >><<
PETS PetMed Express
$28.70 /

+0.3 (+1.06%)

PETS PetMed Express
$28.70 /

+0.3 (+1.06%)

08/04/21 Credit Suisse
PetMed Express assumed with an Underperform at Credit Suisse
06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
05/03/21 Credit Suisse
PetMed Express shares should decline on latest EPS miss, says Credit Suisse
PETS PetMed Express
$28.70 /

+0.3 (+1.06%)

PETS PetMed Express
$28.70 /

+0.3 (+1.06%)

Initiation
PetMed Express assumed with an Underperform at Credit Suisse » 16:26
08/04/21
08/04
16:26
08/04/21
16:26
PETS

PetMed Express

$29.47 /

-0.58 (-1.93%)

Credit Suisse analyst…

Credit Suisse analyst Katie Tryhane assumed coverage of PetMed Express with an Underperform rating and $22 price target. The analyst made no changes to the firm's rating, target price or estimates at this time.

ShowHide Related Items >><<
PETS PetMed Express
$29.47 /

-0.58 (-1.93%)

PETS PetMed Express
$29.47 /

-0.58 (-1.93%)

06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
05/03/21 Credit Suisse
PetMed Express shares should decline on latest EPS miss, says Credit Suisse
03/05/21 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
PETS PetMed Express
$29.47 /

-0.58 (-1.93%)

PETS PetMed Express
$29.47 /

-0.58 (-1.93%)

Hot Stocks
PetMed Express appoints Jodi Watson, Peter Cobb to board of directors » 08:04
08/02/21
08/02
08:04
08/02/21
08:04
PETS

PetMed Express

$31.37 /

+0.71 (+2.32%)

PetMed Express reports…

PetMed Express reports that Jodi Watson and Peter Cobb have been elected to the PetMed Express, Inc. Board of Directors as new independent directors. Watson has held global leadership roles with companies such as Petco, Wolverine Worldwide, Pottery Barn, Williams-Sonoma and Eddie Bauer. She currently works as a CMO, board member and consultant with private equity, venture capital, start-ups and publicly traded companies. Ms. Watson will serve on the PetMed Express, Inc. Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee. Cobb co-founded eBags.com which launched in 1999 and was acquired by Samsonite in 2017. Cobb will also serve on the PetMed Express, Inc. Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee.

ShowHide Related Items >><<
PETS PetMed Express
$31.37 /

+0.71 (+2.32%)

PETS PetMed Express
$31.37 /

+0.71 (+2.32%)

06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
05/03/21 Credit Suisse
PetMed Express shares should decline on latest EPS miss, says Credit Suisse
03/05/21 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
PETS PetMed Express
$31.37 /

+0.71 (+2.32%)

PETS PetMed Express
$31.37 /

+0.71 (+2.32%)

Earnings
PetMed Express reports Q2 EPS 22c, two est. 36c » 08:28
07/26/21
07/26
08:28
07/26/21
08:28
PETS

PetMed Express

$27.75 /

-0.6401 (-2.25%)

Reports Q2 revenue…

Reports Q2 revenue $79.3M, two est. $86.58M. Mendo Akdag, the Company's CEO, commented: "In our first quarter of FY 2022, we faced a unique situation. We were coming off a very strong quarter the previous year that was primarily driven by increased online buying as a result of the pandemic causing many stores to close and many vets to be unavailable. As a result, in the first quarter of FY 2021 consumers increasingly relied on ecommerce. However, during the most recent quarter while the pandemic was abating and stores were re-opening, the advertising market was rapidly recovering with demand driving up ad prices dramatically. As a result, our advertising spending delivered fewer ad impressions than in prior years. Because of this, we believe our advertising spending was less effective in the most recent quarter in its ability to attract new customers. Ad prices may revert back to more normal levels as the pandemic further subsides which may increase the efficiency and effectiveness of our media spending and thereby continue to help us gain new customers. In addition, during the most recent quarter there was a dramatic increase in veterinary visits by consumers who were unable to visit their veterinarians during the pandemic. We believe the increase in veterinary visits was primarily due to pet owners needing to visit their veterinarians for their pets' annual exam and to renew their prescriptions. Since some pet owners purchase medications directly from their vets during their veterinary visit, the Company believes this negatively impacted its sales during the quarter. We would expect to see stronger reorder sales in the back half of FY 2022, as we anticipate more prescriptions being renewed."

ShowHide Related Items >><<
PETS PetMed Express
$27.75 /

-0.6401 (-2.25%)

PETS PetMed Express
$27.75 /

-0.6401 (-2.25%)

06/03/21
Fly Intel: Top five analyst downgrades
06/03/21 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
05/03/21 Credit Suisse
PetMed Express shares should decline on latest EPS miss, says Credit Suisse
03/05/21 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
PETS PetMed Express
$27.75 /

-0.6401 (-2.25%)

PETS PetMed Express
$27.75 /

-0.6401 (-2.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.